Latest Earnings Results: Q3 '26
Estimated EPS
-$0.67
Reported EPS
-$0.50
Surprise
+24.98%
Estimated Rev
$47.73M
Reported Rev
$64.49M
Surprise
+35.11%
• Reported GAAP EPS of -$0.50 up 12.28% YoY • Reported revenue of $64.49M up 18.72% YoY • Schrdinger expects near-term revenue to decline as customers transition to hosted contracts; restructuring and phasing out independent clinical development are expected to yield approximately $70M in savings when fully completed.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$0.26 | -- | -- | N/A |
Q3 '26 | -$0.67 | -$0.50 | 24.98% | BEAT |
Q2 '26 | -$0.41 | $0.08 | 119.30% | BEAT |
Q1 '26 | -$0.62 | -$0.81 | -29.93% | MISSED |
Q4 '25 | -$0.18 | $0.45 | 344.14% | BEAT |